abstract |
Disclosed are compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing the compounds and the use of the compounds of the present invention for the treatment of proliferative disorders such as cancer, viral infections and/or or inflammatory disorders. |